Akorn Provides Second Quarter 2020 Results
August 07, 2020 16:24 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (The OTC Pink Market: AKRXQ), a leading specialty pharmaceutical company, today announced its financial results for the second...
Akorn Animal Health Announces Launch of Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment
June 22, 2020 17:15 ET
|
Akorn, Inc.
LAKE FOREST, Ill., June 22, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (OTC Pink Market: AKRXQ), a leading specialty generic pharmaceutical company, today announced the launch of its Abbreviated New...
Akorn Provides First Quarter 2020 Results
May 11, 2020 17:14 ET
|
Akorn, Inc.
LAKE FOREST, Ill., May 11, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the first quarter of 2020. ...
Akorn Provides Fourth Quarter and Full Year 2019 Results
February 26, 2020 16:58 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended...
Akorn Announces Extension of Standstill Agreement
December 16, 2019 07:51 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that Akorn and certain of its lenders have reached an...
Akorn to Present at the Credit Suisse Healthcare Conference
November 05, 2019 19:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that management will present at the Credit Suisse 28th...
Akorn Provides Preliminary Third Quarter 2019 Results
October 31, 2019 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its preliminary financial results for the third quarter...
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
October 14, 2019 16:25 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application...
Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call
October 14, 2019 13:05 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open...
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%
August 26, 2019 13:35 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug...